Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	As previously reported	Retroactive application of recapitalization (Note 2)	Preferred Stock	Preferred Stock As previously reported	Preferred Stock Retroactive application of recapitalization (Note 2)	Common Stock	Common Stock As previously reported	Common Stock Retroactive application of recapitalization (Note 2)	Additional Paid-in Capital	Additional Paid-in Capital As previously reported	Additional Paid-in Capital Retroactive application of recapitalization (Note 2)	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit As previously reported	Accumulated Deficit Retroactive application of recapitalization (Note 2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)							1,877,233
Ending balance (in shares) at Dec. 31, 2020				0	16,383,725	(16,383,725)	101,286,645	10,838,010	90,448,635
Ending balance at Dec. 31, 2020	$ (18,225)	$ (18,225)	$ 0	$ 0	$ 62,639	$ (62,639)	$ 10	$ 0	$ 10	$ 68,549	$ 5,920	$ 62,629		$ (86,784)	$ (86,784)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,610									1,610
Issuance of common stock upon exercise of stock options (in shares)							171,724
Issuance of common stock upon exercise of stock options	85									85
Net loss	(11,509)													(11,509)
Ending balance (in shares) at Mar. 31, 2021				0			101,458,369
Ending balance at Mar. 31, 2021	(28,039)			$ 0			$ 10			70,244				(98,293)
Beginning balance (in shares) at Dec. 31, 2020				0	16,383,725	(16,383,725)	101,286,645	10,838,010	90,448,635
Beginning balance at Dec. 31, 2020	(18,225)	(18,225)	0	$ 0	$ 62,639	$ (62,639)	$ 10	$ 0	$ 10	68,549	5,920	62,629		(86,784)	(86,784)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in net unrealized loss on available-for-sale securities, net of tax	0
Net loss	(22,584)
Ending balance (in shares) at Jun. 30, 2021				0			101,466,847
Ending balance at Jun. 30, 2021	(36,490)			$ 0			$ 10			72,868				(109,368)
Beginning balance (in shares) at Dec. 31, 2020				0	16,383,725	(16,383,725)	101,286,645	10,838,010	90,448,635
Beginning balance at Dec. 31, 2020	(18,225)	$ (18,225)	$ 0	$ 0	$ 62,639	$ (62,639)	$ 10	$ 0	$ 10	68,549	$ 5,920	$ 62,629		(86,784)	$ (86,784)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)							204,119
Beginning balance (in shares) at Mar. 31, 2021				0			101,458,369
Beginning balance at Mar. 31, 2021	(28,039)			$ 0			$ 10			70,244				(98,293)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,620									2,620
Issuance of common stock upon exercise of stock options (in shares)							8,478
Issuance of common stock upon exercise of stock options	4									4
Change in net unrealized loss on available-for-sale securities, net of tax	0
Net loss	(11,075)													(11,075)
Ending balance (in shares) at Jun. 30, 2021				0			101,466,847
Ending balance at Jun. 30, 2021	(36,490)			$ 0			$ 10			72,868				(109,368)
Beginning balance (in shares) at Dec. 31, 2021				0			155,137,237
Beginning balance at Dec. 31, 2021	168,767			$ 0			$ 16			320,937			$ (391)	(151,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,340									5,340
Issuance of common stock upon exercise of stock options (in shares)							656,303
Issuance of common stock upon exercise of stock options	222									222
Issuance of common stock upon vesting of restricted stock units (in shares)							856,917
Taxes related to net share settlement of equity awards (in shares)							(285,533)
Taxes related to net share settlement of equity awards	(1,149)									(1,149)
Change in net unrealized loss on available-for-sale securities, net of tax	(1,056)												(1,056)
Net loss	(24,881)													(24,881)
Ending balance (in shares) at Mar. 31, 2022				0			156,364,924
Ending balance at Mar. 31, 2022	147,243			$ 0			$ 16			325,350			(1,447)	(176,676)
Beginning balance (in shares) at Dec. 31, 2021				0			155,137,237
Beginning balance at Dec. 31, 2021	$ 168,767			$ 0			$ 16			320,937			(391)	(151,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,761,601
Change in net unrealized loss on available-for-sale securities, net of tax	$ (1,238)
Net loss	(51,348)
Ending balance (in shares) at Jun. 30, 2022				0			158,475,630
Ending balance at Jun. 30, 2022	127,588			$ 0			$ 16			332,344			(1,629)	(203,143)
Beginning balance (in shares) at Mar. 31, 2022				0			156,364,924
Beginning balance at Mar. 31, 2022	147,243			$ 0			$ 16			325,350			(1,447)	(176,676)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,557									6,557
Issuance of common stock upon exercise of stock options (in shares)							1,105,298
Issuance of common stock upon exercise of stock options	446									446
Issuance of common stock upon vesting of restricted stock units (in shares)							883,318
Taxes related to net share settlement of equity awards (in shares)							(312,920)
Taxes related to net share settlement of equity awards	(1,431)									(1,431)
Issuance of common stock under Common Stock Purchase Agreement (in shares)							435,000
Issuance of common stock under the Common Stock Purchase Agreement	1,422									1,422
Issuance of stock upon exercise of public warrants (in shares)							10
Change in net unrealized loss on available-for-sale securities, net of tax	(182)												(182)
Net loss	(26,467)													(26,467)
Ending balance (in shares) at Jun. 30, 2022				0			158,475,630
Ending balance at Jun. 30, 2022	$ 127,588			$ 0			$ 16			$ 332,344			$ (1,629)	$ (203,143)